Is Pfizer’s Hidden Value Ignored By Wall Street
The rise and fall of Pfizer (NYSE: PFE) over the past few years has been truly historic. At the peak of the pandemic shares nearly breached $60 before being …
The rise and fall of Pfizer (NYSE: PFE) over the past few years has been truly historic. At the peak of the pandemic shares nearly breached $60 before being …
It’s been a wild ride for Moderna (NASDAQ: MRNA) having traded just under $500 two years ago, about 5x higher than where it resides today. The …
Dividend stocks offer a timeless appeal, particularly for billionaires. While high-risk, high-reward strategies can be exciting, there’s something deeply …
Positive trial data is the lifeblood that fuels success in the pharmaceutical business. It’s the beacon of hope that illuminates the path to regulatory …
In the complex world of pharmaceutical research, it’s no stretch to say that intellectual property is the lifeblood of innovation and the ultimate …
Longitudinal studies of the stock market show that its behavior takes on patterns over time. For example, the market moves in a cyclical manner, and …
CureVac is a German biotechnology company that specializes in the development of messenger RNA (mRNA) vaccines and therapies. CureVac has been focused on using …
In this article, we’ll take a look at five dividend-paying large-cap companies whose businesses are all extremely profitable. And yet, while they share the …
Is Vanguard High Yield Dividend Index Fund Stock A Buy? Growth investors and income investors look at the market differently. Growth investors are focused on a …
Will Pfizer Go Up? The COVID crisis of 2020 turned out to be a significant growth driver for the multinational drug company Pfizer and its German counterpart, …
Inflation is at a 40-year high, and soaring interest rates have made it almost impossible for companies to raise funds and improve their operations in an …
Best Blue Chip Dividend Stock To Buy: While share prices tank – and wage growth fails to keep up with inflation – there’s never been a better …
Pfizer vs Moderna Legal Battle: American biotechnology firm Moderna emerged as one of the most widely-recognized success stories of the coronavirus era. The …
In the investment world, it seems that the slow and steady approach always wins the race. Indeed, a reliable business with a rock-solid dividend is practically …
Regeneron Pharma Stock Forecast: Despite centuries of progress in medicine – and a collection of high-impact advances in the past 50 years – …
How Did Stocks Do During Stagflation? Before the pandemic, inflation was at a comfortable 2.5 percent. Most consumers were able to keep up with the gradual …
Having already owned 4.2 million shares of Exelixis stock at the end of 2021, billionaire investor Steven Cohen added another 2.6 million to take his stake in …
The biotech sector suffered a mixed run of fortunes lately. While some industry stalwarts, like Pfizer, Stryker, and Roche, are down double digits this year, …
When brick-and-mortar stores were out of the question for anxious consumers during the COVID-19 pandemic, Amazon came to the rescue. Essentials like groceries …
The healthcare industry can be a promising place to invest. New drugs and treatments are developed all the time, and sometimes these findings generate massive …